Fauci: U.S. will likely resume use of J&J vaccine with a warning or restriction
J&J Privately Asked Rival Covid-19 Vaccine Makers to Probe Clotting Risks
CMS pulls major Texas Medicaid waiver over concerns Trump admin hastily approved it...
UnitedHealth’s Optum To Broaden Telehealth Offerings In All 50 States...
Payers, providers clash over telehealth reimbursement as Congress mulls changes...
Private equity's estimated healthcare spending halved in first quarter...
Lyft Pass for Healthcare lets patients book their own rides to the doctor...
Lawmakers urge HHS to conduct 'vigorous oversight' of hospital price posts after reports of noncompliance...
Omada's latest MSK tech empowers physical therapists to conduct remote appointments...
UnitedHealth Group beats the Street with $4.9B in Q1 profit...
Oscar Health taps new president for its medical group...
California re-opens enrollment for health insurance coverage...
Mayo Clinic launches two companies to create digital health care tools
Anthem, K Health, Blackstone launching joint digital health venture...
Democrats, led by Biden, are aiming big on healthcare...
UnitedHealth study: Medicare Advantage members spend 40% less per year than fee-for-service beneficiaries...
Aetna, Fresenius partner on value-based kidney care for Medicare Advantage members...
Walgreens Expands Covid-19 Vaccines To 49 States...
Microsoft to buy AI firm Nuance Communications for about $16 billion in healthcare push...
BCBS of Minnesota parent to sell health savings account unit for $500M...
Devoted Health, onehome partner on home health for Medicare Advantage members...
Cigna, Oscar Health expanding reach of cobranded plans in California...
You Might Like
CORONAVIRUS
Half of U.S. adults have received at least one Covid shot in milestone for vaccination campaign...
AstraZeneca could have COVID-19 vaccine against variant by end-2021 -Austrian newspaper...
The Covid-19 Plasma Boom Is Over. What Did We Learn From It?
FDA asks Emergent plant behind botched COVID-19 vaccines to pause manufacturing...
EMA starts review of GSK's monoclonal antibody to treat COVID-19 patients...
Drug overdose deaths surged during coronavirus pandemic...
Moderna hopes to have Covid booster shot for its vaccine ready by the fall, CEO says...
Merck to continue tests of Covid pill, but stop trial in hospitalized patients...
Elderly show equally strong antibody response to first dose of Astra, Pfizer COVID-19 shots...
AstraZeneca shot is good if safety issues can be overcome, Fauci says...
Scientists work toward an elusive dream: a simple pill to treat Covid-19...
Michigan hospitals start reducing elective procedures in wake of COVID-19 patient surge...
The world is watching the FDA's AstraZeneca decision...
U.S. begins study assessing allergic reactions to Pfizer and Moderna Covid vaccines...
CDC director says hospitalizations among seniors are declining as more than half of the age group is fully vaccinated...
Some people with ‘long Covid’ say their symptoms ease after getting vaccine...
1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds...
Many Children With Serious Inflammatory Syndrome Had No Covid Symptoms...
CDC director says hospitalizations among seniors are declining as more than half of the age group is fully vaccinated...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
J&J, others face California trial over claims they fueled opioid epidemic...
China is starting clinical trials of a Covid vaccine that can be inhaled...
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab...
China likely to approve BioNTech's COVID-19 vaccine by July...
Pfizer CEO says third Covid vaccine dose likely needed within 12 months...
Thermo Fisher to buy contract researcher PPD for $17.4 billion...
Cancer biotech Tango Therapeutics picks a SPAC as its IPO dance partner...
PhRMA’s new message to Washington: Don’t take us for granted...
Moderna says new data shows its Covid vaccine is more than 90% effective against virus six months after second shot...
Novavax says supply shortages delaying full-speed production of its COVID-19 vaccine...
Biotech startup Repertoire adds $189M to expand array of immune medicines...
Regeneron to request FDA clearance to use Covid antibody drug as a preventative treatment...
Eli Lilly to focus on selling COVID-19 antibody drug combination...
Sanofi buys an mRNA startup in another bet on 'off-the-shelf' cell therapy...
U.S. lab products provider Avantor to buy Germany's Ritter for $1.1B...
J&J Covid-19 Vaccine Deliveries to Drop Significantly Next Week...
EU reviews J&J COVID-19 vaccine for blood clots, expands AstraZeneca probe...
Eli Lilly's arthritis drug fails to prevent mechanical ventilation in COVID-19 patients...
Liva Healthcare and Amgen partner to improve access to cardiac rehabilitation...
You Might Like
